SCHEMBL726356

SCHEMBL726356

CC1=CCC(c2nn(C(C)(C)CNC(=S)NC(=O)c3ccccc3)c3ncnc(N)c23)C=C1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RET P07949 10/20 0.57
RIPK2 O43353 2/20 0.45
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
ALOX12 P18054 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDR P35968 4/20 0.33
BTK Q06187 2/20 0.33
EGFR P00533 1/20 0.33
ABL1 P00519 1/20 0.33
SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL727933 0.92 RET (0.62) RETRIPK2KDRBTKEGFR
SCHEMBL10098363 0.85 RET (0.61) RETRIPK2KDRBTKEGFR
SCHEMBL728046 0.84 RET (0.69) RETRIPK2ALDH1A1KDRBTK
SCHEMBL726555 0.84 RET (0.60) RETRIPK2BTKEGFRABL1
SCHEMBL726637 0.80 RET (0.76) RETRIPK2ALDH1A1CYP1A2CYP2C9
SCHEMBL726820 0.78 RIPK2 (0.72) RETRIPK2ALDH1A1CYP1A2CYP3A4
SCHEMBL728142 0.78 RET (0.57) RETRIPK2KDRBTKEGFR
SCHEMBL726987 0.77 RET (0.71) RETRIPK2ALDH1A1CYP1A2CYP2C9
SCHEMBL726969 0.75 RET (0.77) RETRIPK2ALDH1A1CYP1A2CYP3A4
SCHEMBL726350 0.74 RET (0.66) RETRIPK2ALDH1A1SMN1; SMN2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003544-A1 PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2012-01-12 WO disclosed